The FDA is unequivocal that "retatrutide and cagrilintide cannot be used in compounding under federal law." "These are not components of FDA-approved drugs and have not been found safe and effective for any condition," the agency said in drug safety information posted online
Scocchi M, Bontempo D, Boscolo S, Tomasinsig L, Giulotto E, Zanetti M: Novel cathelicidins in horse leukocytes
As a result, enzymatic activity is diverted away from nutrient activation, storage, and methylation processes
Research shows that it reduces damage from UV radiation, helps minimize pigmentation issues, and smooths fine lines and wrinkles
Research shows BPC-157 restores healing in corticosteroid-impaired tissue, potentially making it valuable for patients who have undergone steroid injections
Unlike traditional weight loss medications, compounded weight loss medications are more personalized to the individuals needs